Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 0

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 0
---
As filed with the U.S. Securities and Exchange Commission on July 25, 2025. Registration No. 333-288289 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

| ​                                                      |
| Liminatus Pharma, Inc.                                 |
| (Exact name of registrant as specified in its charter) |

| ​                               | ​ |                            ​ | ​ | ​                  |
| Delaware                        |   |                         6770 |   | 93-2710748         |
| (State or other jurisdiction of 
 incorporation or organization)  | ​ | -Primary Standard Industrial 
   Classification Code Number | ​ | -I.R.S. Employer   
 Identification No. |

6 Centerpointe Drive #625 La Palma, California 90623 Tel: (213) 273-5453 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Chris Kim 6 Centerpointe Drive #625 La Palma, California 90623 Tel: (213) 273-5453 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Mitchell S. Nussbaum
Giovanni Caruso
Loeb & Loeb LLP
345 Park Avenue
New York, NY 10154
Telephone: (212) 407-4000 Approximate date of commencement of proposed sale to public: From time to time after the effective date hereof. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration